Lazard Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $78.9M | Buy |
|
|||||
|
2025
Q2 | $87.3M | Buy |
|
|||||
|
2025
Q1 | $85.9M | Sell |
|
|||||
|
2024
Q4 | $109M | Sell |
|
|||||
|
2024
Q3 | $156M | Buy |
|
|||||
|
2024
Q2 | $165M | Sell |
|
|||||
|
2024
Q1 | $159M | Sell |
|
|||||
|
2023
Q4 | $151M | Sell |
|
|||||
|
2023
Q3 | $136M | Buy |
|
|||||
|
2023
Q2 | $85.7M | Buy |
|
|||||
|
2023
Q1 | $864K | Buy |
|
|||||
|
2022
Q4 | $715K | Sell |
|
|||||
|
2022
Q3 | $615K | Buy |
|
|||||
|
2022
Q2 | $2K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $160K | Sell |
|
|||||
|
2018
Q1 | $198K | Sell |
|
|||||
|
2017
Q4 | $219K | Hold |
|
|||||
|
2017
Q3 | $196K | Sell |
|
|||||
|
2017
Q2 | $8.95M | Sell |
|
|||||
|
2017
Q1 | $7.23M | Buy |
|
|||||
|
2016
Q4 | $7.47M | Sell |
|
|||||
|
2016
Q3 | $12.9M | Sell |
|
|||||
|
2016
Q2 | $102M | Buy |
|
|||||
|
2016
Q1 | $101M | Buy |
|
|||||
|
2015
Q4 | $102M | Sell |
|
|||||
|
2015
Q3 | $116M | Buy |
|
|||||
|
2015
Q2 | $114M | Buy |
|
|||||
|
2015
Q1 | $107M | Sell |
|
|||||
|
2014
Q4 | $85.4M | Sell |
|
|||||
|
2014
Q3 | $135M | Sell |
|
|||||
|
2014
Q2 | $171M | Buy |
|
|||||
|
2014
Q1 | $164M | Buy |
|
|||||
|
2013
Q4 | $121M | Buy |
|
|||||
|
2013
Q3 | $70.3M | Buy |
|
|||||
|
2013
Q2 | $177K | Buy |
|